Organic Letters
Letter
(21) Over the years, there have been numerous synthetic studies
toward aromatic polycyclic terpenoids; see: (a) Ho, T.-L. Carbocycle
Construction in Terpene Synthesis; Wiley-VCH: Weinheim, 1988.
(b) Banerjee, A. K.; Laya, M. S.; Mora, H. R.; Cabrera, E. V. Curr.
Org. Chem. 2008, 12, 1050−1070. (c) Dhambri, S.; Mohammad, S.;
Van Buu, O. N.; Galvani, G.; Meyer, Y.; Lannou, M.-I.; Sorin, G.;
REFERENCES
■
(1) (a) Quaternary Stereocenters: Challenges and Solutions for Organic
Synthesis; Christoffers, J., Baro, A., Eds.; Wiley-VCH: Weinheim, 2005.
(b) Ling, T.; Rivas, F. Tetrahedron 2016, 72, 6729−6777. (c) Liu, Y.;
Han, S.-J.; Liu, W.-B.; Stoltz, B. M. Acc. Chem. Res. 2015, 48, 740−751.
(d) Quasdorf, K. L.; Overman, L. E. Nature 2014, 516, 181−191.
(2) For reviews, see: (a) Sivanandan, S. T.; Shaji, A.; Ibnusaud, I.;
Seechurn, C. C. C. J.; Colacot, T. J. Eur. J. Org. Chem. 2015, 2015, 38−
Ardisson, J. Nat. Prod. Rep. 2015, 32, 841−864. (d) Gonzal
́
ez, M. A.
Tetrahedron 2015, 71, 1883−1908.
(22) Baraza, L. D.; Joseph, C. C.; Munissi, J. J. E.; Nkunya, M. H. H.;
Arnold, N.; Porzel, A.; Wessjohann, L. Phytochemistry 2008, 69, 200−
205.
́
49. (b) Novak, P.; Martin, R. Curr. Org. Chem. 2011, 15, 3233−3262.
(c) Bellina, F.; Rossi, R. Chem. Rev. 2010, 110, 1082−1146. (d) Culkin,
D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234−245. (e) Miura, M.;
Nomura, M. Top. Curr. Chem. 2002, 219, 211−241.
(23) In a recent paper, cytotoxic activity of compound 9 was
evaluated against human myeloid leukemia (HL-60), hepatocellular
carcinoma (SMMC-7721), lung cancer (A-549), breast cancer (MCF-
7), and colon cancer (SW480) cell lines; see: Cheng, L.; Ji, K.; Liao, S.-
g.; Gan, L.-S.; Yang, L.; Cao, D.-h.; Liu, Y.-q.; Guo, J.; Zhang, P.; Lu,
C.-l.; Hu, H.-b.; Xu, Y.-k. Tetrahedron Lett. 2016, 57, 2262−2265.
(24) Chao, C.-H.; Cheng, J.-C.; Shen, D.-Y.; Wu, T.-S. J. Nat. Prod.
2014, 77, 22−28.
́ ́
(3) For selected key advances, see: (a) Franzoni, I.; Guenee, L.;
Mazet, C. Chem. Sci. 2013, 4, 2619−2624. (b) Huang, D. S.; Hartwig,
J. F. Angew. Chem., Int. Ed. 2010, 49, 5757−5761. (c) Hyde, A. M.;
Buchwald, S. L. Org. Lett. 2009, 11, 2663−2666.
(4) Hyde, A. M.; Buchwald, S. L. Angew. Chem., Int. Ed. 2008, 47,
177−180.
(5) Lightly substituted targets were conventionally prepared by
Robinson-type annulation. For selected examples, see: (a) Martinez, L.
P.; Umemiya, S.; Wengryniuk, S. E.; Baran, P. S. J. Am. Chem. Soc.
2016, 138, 7536−7539. (b) Yang, H.; Carter, R. G. Org. Lett. 2010, 12,
3108−3111. (c) Inokoishi, Y.; Sasakura, N.; Nakano, K.; Ichikawa, Y.;
Kotsuki, H. Org. Lett. 2010, 12, 1616−1619. (d) Otani, G.; Yamada, S.-
I. Chem. Pharm. Bull. 1973, 21, 2112−2118. For a dearomatization
(25) Xu, J.; Peng, M.; Sun, X.; Liu, X.; Tong, L.; Su, G.; Ohizumi, Y.;
Lee, D.; Guo, Y. Bioorg. Med. Chem. Lett. 2016, 26, 4785−4789.
(26) Zhang, C. L.; Zhu, X. L.; Ma, Y. G.; Zou, L. W. Chin. Chem. Lett.
2006, 17, 163−164.
(27) Majetich, G.; Liu, S.; Fang, J.; Siesel, D.; Zhang, Y. J. Org. Chem.
1997, 62, 6928−6951.
(28) Du, Z.-T.; Zheng, S.; Chen, G.; Lv, D. Molecules 2011, 16,
8053−8061.
́
approach, see: (e) Guerard, K. C.; Sabot, C.; Racicot, L.; Canesi, S. J.
(29) Liu, H.-J; Shia, K.-S.; Shang, X.; Zhu, B.-Y. Tetrahedron 1999,
55, 3803−3830.
Org. Chem. 2009, 74, 2039−2045. For an alkene isomerization
approach, see: (f) Kress, S.; Johnson, T.; Weisshar, F.; Lautens, M.
ACS Catal. 2016, 6, 747−750.
(6) For recent applications of the Stork−Danheiser transposition,
see: (a) Yu, G.; Clive, D. L. J. J. Org. Chem. 2016, 81, 8470−8484.
(b) Das, M. K.; De, S.; Shubhashish; Bisai, A. Synthesis 2016, 48,
2093−2104. (c) Bennett, N. B.; Hong, A. Y.; Harned, A. M.; Stoltz, B.
M. Org. Biomol. Chem. 2012, 10, 56−59.
(30) Stork, G.; Rosen, P.; Goldman, N.; Coombs, R. V.; Tsuji, J. J.
Am. Chem. Soc. 1965, 87, 275−286.
(31) Gemal, A. L.; Luche, J. L. J. Am. Chem. Soc. 1981, 103, 5454−
5459.
(32) Parish, E. J.; Chitrakorn, S.; Wei, T.-Y. Synth. Commun. 1986,
16, 1371−1375.
(7) Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775−1776.
(8) Zhao, Y.; Zhou, Y.; Liang, L.; Yang, X.; Du, F.; Li, L.; Zhang, H.
Org. Lett. 2009, 11, 555−558.
(9) Synthesis of a α-aryl quaternary center-containing vinylogoues
ester was accomplished via a three-step sequence with tricarbonyl(4-
methoxycyclohexadienyl)iron complex acting as the formal aryl donor;
see: Pearson, A. J.; Richards, I. C.; Gardner, D. V. J. Org. Chem. 1984,
49, 3887−3891.
(10) Johnson, T.; Pultar, F.; Menke, F.; Lautens, M. Org. Lett. 2016,
18, 6488−6491.
(11) Compound 1a can be prepared from 1,3-cyclohexanedione in
three steps on multigram scale; see: Pirrung, M. P. J. Am. Chem. Soc.
1981, 103, 82−87.
(12) Selected reaction conditions are summarized in Table 1. So far,
we observed that only sterically demanding phosphines are effective in
this transformation. Employing toluene, instead of ether-type solvents,
enables the reaction to occur more cleanly at room temperature.
(13) Jørgensen, M.; Lee, S.; Liu, X.; Wolkowski, J. P.; Hartwig, J. F. J.
Am. Chem. Soc. 2002, 124, 12557−12565.
(14) Netherton, M. R.; Fu, G. C. Org. Lett. 2001, 3, 4295−4298.
(15) This obscure reactivity is presumably due to the catalyst
poisoning by the quinolone nitrogen.
(16) Itokawa, H.; Ichihara, Y.; Takeya, K.; Morita, H.; Motidome, M.
Phytochemistry 1991, 30, 4071−4073.
(17) Ravindranath, N.; Ravinder Reddy, M.; Ramesh, C.; Ramu, R.;
Prabhakar, A.; Jagadeesh, B.; Das, B. Chem. Pharm. Bull. 2004, 52,
608−611.
(18) Burnell, R. H.; Dumont, N.; Theb
Commun. 1992, 22, 2571−2578.
(19) Hanson, J. R. Nat. Prod. Rep. 2016, 33, 1227−1238 and
references cited therein.
́ ́
erge, N.; Desfosses, S. Synth.
(20) (a) Ara, I.; Siddiqui, B. S.; Faizi, S.; Siddiqui, S. Phytochemistry
1988, 27, 1801−1804. (b) Burnell, R. H.; Dumont, N.; Theb
́
erge, N. J.
Nat. Prod. 1993, 56, 1930−1936.
D
Org. Lett. XXXX, XXX, XXX−XXX